Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.


IDSA Resources: Infection

SCCM’s COVID-19 Rapid Resource Center now links to pertinent content from the Infectious Diseases Society of America (IDSA) COVID-19 Real-Time Learning Network. These resources are categorized as Infection

The information provided is for educational purposes for SCCM members and the general public. Clicking on these links allows users to leave www.sccm.org. The Society does not control the linked sites or the content on those sites. SCCM does not assume any liability for the content or information contained on these linked sites. Further, SCCM does not assume any liability or warrant with respect to the quality, noninfringement, accuracy, completeness, timeliness, or reliability of such linked sites.You should be aware that other internet sites that link to the Site may contain privacy provisions that differ from these policies. To ensure that your privacy is protected, we recommend that you review the privacy policies of other internet sites you visit.

The Latest on Long COVID
Date Added: 5/19/2022
Dr. Kathleen Bell, Professor and Chair of the Department of Physical Medicine and Rehabilitation at UT Southwestern Medical Center, and Dr. Nahid Bhadelia, associate professor of infectious diseases at Boston University School of Medicine and founding director of the BU Center of Emerging Infectious Diseases Policy and Research, discuss the latest research and information on long COVID.

CDC/IDSA COVID-19 Clinician Call Registration
Date Added: 3/31/2022
These webinars, held Saturdays at 3 p.m. ET, focus on timely issues of relevance to clinicians and feature case presentations by experts in the field, synthesis of new data, and an opportunity to engage with colleagues.

IDSA Media Briefing: The Latest on Long COVID (Webinar)
Date Added: 2/16/2022
A media briefing with experts from the Infectious Diseases Society of America to discuss COVID-19 developments including current knowledge base around long COVID management and patients, long COVID and health inequities, unanswered research questions, questions from media.

CDC/IDSA Clinician Call: COVID-19 Treatment Updates Plus the Latest on Omicron (Webcast)
Date Added: 2/4/2022
COVID-19 Treatment Updates and the Latest on Omicron: Key questions we're trying to answer: How transmissible is Omicron?, How severe is Omicron compared to other variants?, How well do vaccines and prior infection protect against infection, transmission, clinical disease, and death due to Omicron?
 
Vaccine FAQ - What is known about the "Omicron" variant of SARS-CoV-2?
Date Added: 1/21/2022
The Omicron variant differs from previous variants of SARS-CoV-2 in the increased number of mutations present in the spike protein, relative to previous variants such as beta and delta. These mutations may have implications for diagnostic testing, transmissibility, and neutralization by vaccine-induced antibodies. The impact on disease severity remains to be characterized.
 
Other Therapies/Molnupiravir
Date Added: 12/16/2021
Molnupiravir (name derived from Mjölnir, the hammer of the Norse thunder god, Thor; formerly called EIDD-2801 and MK-4482) is a readily bioavailable prodrug of a ribonucleoside analogue that interferes with multiple SARS-CoV-2 viral processes, including replication. It also acts potently against several other RNA viruses, including Ebola, influenza, MERS-CoV and Venezuelan equine encephalitis virus.
 
Multisystem Inflammatory Syndrome in Adults after SARS-CoV-2 infection and COVID-19 vaccination
Date Added: 12/16/2021
Multisystem inflammatory syndrome in adults (MIS-A) is a rare but serious condition that can occur weeks after SARS CoV-2 infection and COVID-19 illness.
 
IDSA Media Briefing: Omicron Variant
Date Added: 12/16/2021
Updates on the omicron variant; Virology of the variant; Indicators to watch; Implications of new variant on public health response; Treatment options
 
Clinical Infectious Diseases: Multisystem Inflammatory Syndrome in Children—United States, February 2020–July 2021
Date Added: 12/16/2021
Over the first 3 pandemic waves of MIS-C in the United States, cardiovascular complications and clinical outcomes including length of hospitalization, receipt of ECMO, and death decreased over time. These data serve as a baseline for monitoring future trends associated with SARS-CoV-2 B.1.617.2 (Delta) or other variants and increased COVID-19 vaccination among children.
 
CDC/IDSA COVID-19 Clinician Call: Updates in COVID-19 Treatment and Antibody-Based Prevention
Date Added: 12/16/2021
Topics included Updates in COVID-19 Treatment and Antibody-Based Prevention, Treatment of the Immunocompromised Patient, and Treatment in the Era of Oral Antivirals.
 
CDC/IDSA COVID-19 Clinician Call: Omicron Update Plus the Latest on Molnupiravir
Date Added: 12/16/2021
Topics included The Latest on Molnupiravir, Omicron Update, Viral Surveillance Update, and Addressing Diagnostic Challenges.
 
Vaccine Boosters Versus The Delta Variant (podcast)
Date Added: 11/15/2021
How is the Delta variant impacting COVID-19 vaccine performance? Why are only certain populations being considered for boosters? Steven Pergam, MD, FIDSA of the Fred Hutchinson Cancer Research Center and Walter Orenstein, MD, FIDSA of Emory University answer these questions and more.
 
MIS-A
Date Added: 9/27/2021
This IDSA resources details Multisystem Inflammatory Syndrome in Adults (MIS-A).
 
CDC/IDSA COVID-19 Clinician Call: Post-COVID Conditions
Date Added: 6/17/2021
In this webinar, the lastest in post-COVID conditions will be discussed.
 
CDC/IDSA COVID-19 Clinician Call: Emerging SARS-CoV-2 Variants: Updates & Implications
Date Added: 2/25/2021
This is a link to the IDSA Real-Time Learning Network Clinicians Call regarding emerging SARS-CoV-2 variants.  
 
Long COVID and the Road to Recovery Podcast
Date Added: 2/17/2021
This is a link to the IDSA Real-Time Learning Network podcast regarding what’s currently known about the mysterious syndrome and the challenges it presents to patients and clinicians.  
 
COVID-19: Emerging Variants & the Race to Vaccinate Podcast
Date Added: 2/17/2021
This is a link to the IDSA Real-Time Learning Network podcast regarding emerging variants and the race to vaccinate. 
 
Co-Infection and Antimicrobial Stewardship
Date Added: 2/4/2021
This is a link to the IDSA Real-Time Learning Network external resources regarding COVID-19, co-infection and antimicrobial stewardship.
 
Creating Safer Hospital Environments
Date Added: 1/20/2021
The faculty IDSA Board member John Lynch, M.D., FIDSA, & SHEA/IDSA member Erica Shenoy, M.D., FIDSA discuss how to create safe environments across medical facility departments while treating COVID-19 patients. This episode was produced in partnership with the Society for Healthcare Epidemiology of America (SHEA).
 
COVID-19 & Influenza
Date Added: 12/14/2020
Information regarding COVID-19 and influenza.

COVID-19 Data: The Forecast for the Upcoming Months
Date Added: 12/14/2020
What does COVID-19 data modeling tell us to expect over the next six months? Amesh Adalja, M.D., FIDSA of Johns Hopkins University and Ali Mokdad, PhD of the Institute for Health Metrics and Evaluation join us to share the forecast.  

CDC/IDSA COVID-19 Clinician Calls
Date Added: 12/14/2020
This is a link to the IDSA Real-Time Learning Network external resources regarding COVID-19.


Estimated Time:

Categories: Disaster, Infection,
Content Type: External Resource,